PHARMARELATIONS AS

0484 OSLO

Finances

Share Ownership

Return on Equity

59,24 %

Current Ratio

1,99

Debt-to-Equity Ratio

0,35

Key figures (NOK)	2022	2021	2020	2019
Revenue	20 206 000	11 106 000	11 605 000	13 734 000
Net Income	1 869 000	675 000	−207 000	794 000
Total Assets	8 522 000	4 128 000	3 621 000	4 176 000
Total Equity	3 155 000	1 286 000	611 000	817 000

Income (NOK)	2022	2021	2020	2019
Revenue	20 206 000	11 106 000	11 605 000	13 734 000
Expenditure	17 803 000	10 229 000	11 875 000	12 693 000
Operating Profit	2 404 000	877 000	−270 000	1 040 000
Financial Income	28 000	0	13 000	1 000
Financial Costs	35 000	9 000	7 000	26 000
Financial Balance	−7 000	−9 000	6 000	−25 000
Earnings Before Tax	2 397 000	867 000	−264 000	1 016 000
Tax	527 000	192 000	−57 000	222 000
Net Income	1 869 000	675 000	−207 000	794 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	64 000	46 000	27 000	18 000
Total Current Assets	8 458 000	4 083 000	3 595 000	4 158 000
Total Assets	8 522 000	4 128 000	3 621 000	4 176 000
Total Retained Equity	3 125 000	1 256 000	581 000	787 000
Total Equity	3 155 000	1 286 000	611 000	817 000
Total Long-Term Debt	1 115 000	1 083 000	1 383 000	661 000
Total Current Debt	4 252 000	1 759 000	1 627 000	2 698 000
Total Equity and Debt	8 522 000	4 128 000	3 621 000	4 176 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	20 206 000	11 106 000	11 591 000	13 734 000
Other Income	0	0	15 000	0
Revenue	20 206 000	11 106 000	11 605 000	13 734 000
Cost of Goods Sold	0	0	0	0
Salary Costs	13 103 000	7 853 000	9 315 000	9 506 000
Depreciation	0	0	0	0
Impairment	0	0	0	0
Expenditure	17 803 000	10 229 000	11 875 000	12 693 000
Operating Profit	2 404 000	877 000	−270 000	1 040 000
Financial Income	28 000	0	13 000	1 000
Financial Costs	35 000	9 000	7 000	26 000
Financial Balance	−7 000	−9 000	6 000	−25 000
Dividends	0	0	0	0
Net Income	1 869 000	675 000	−207 000	794 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	0	0	0	0
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	0	0	0	0
Total Tangible Assets	0	0	0	0
Total Fiancial Fixed Assets	64 000	46 000	27 000	18 000
Total Fixed Assets	64 000	46 000	27 000	18 000
Stock	0	0	0	0
Total Investments	0	0	0	0
Cash, Bank	1 578 000	1 809 000	1 240 000	1 302 000
Total Current Assets	8 458 000	4 083 000	3 595 000	4 158 000
Total Assets	8 522 000	4 128 000	3 621 000	4 176 000
Total Equity	3 155 000	1 286 000	611 000	817 000
Short-Term Group Debt	0	0	0	632 000
Total Long-Term Debt	1 115 000	1 083 000	1 383 000	661 000
Creditors	187 000	269 000	103 000	110 000
Unpaid Taxes	1 832 000	590 000	811 000	789 000
Dividends	0	0	0	0
Other Current Debt	1 706 000	709 000	713 000	945 000
Total Current Debt	4 252 000	1 759 000	1 627 000	2 698 000
Total Equity and Debt	8 522 000	4 128 000	3 621 000	4 176 000

Financial indicators	2022	2021	2020	2019
Return on Equity	59,24 %	52,49 %	−33,88 %	97,18 %
Debt-to-Equity Ratio	0,35	0,84	2,26	0,81
Operating Profit Margin	11,9 %	7,9 %	−2,33 %	7,57 %
Current Ratio	1,99	2,32	2,21	1,54
Quick Ratio	1,99	2,32	2,21	1,54
Equity Ratio	0,37	0,31	0,17	0,2
Gross Profit Margin	100 %	100 %	100 %	100 %